Suppr超能文献

[两种哌唑嗪制剂在原发性高血压患者中的相对生物利用度比较研究]

[Comparative study of the relative bioavailabilities of two prazosin preparations in patients with essential hypertension].

作者信息

Rostock G, Faulhaber H D, Unger P, Homuth V, Prehm C, Günzel R

出版信息

Pharmazie. 1985 Apr;40(4):259-61.

PMID:4011659
Abstract

The relative bioavailability of two different Prazosine preparations (Adversuten, VEB Arzneimittelwerk Dresden, GDR and Minipress, Pfizer GmbH, Karlsruhe, FRG) has been determined in 10 patients suffering from an essential hypertension by the cross-over test following a single oral application. The plasma concentrations determined on the same conditions revealed with both the preparations an almost equal blood level course. The pharmacokinetic parameters had been determined to the one-compartment system, demonstrating not any significant differences. Compared to the Minipress, the relative bioavailability of the preparation Adversuten was calculated to 102%. The discussion enters into a possible influence on the distribution parameters by alterations of the kidney function.

摘要

通过单次口服后的交叉试验,在10例原发性高血压患者中测定了两种不同哌唑嗪制剂(Adversuten,民主德国德累斯顿VEB制药厂生产;Minipress,联邦德国卡尔斯鲁厄辉瑞有限公司生产)的相对生物利用度。在相同条件下测定的血浆浓度显示,两种制剂的血药浓度过程几乎相同。已对单室系统的药代动力学参数进行了测定,未显示出任何显著差异。与Minipress相比,Adversuten制剂的相对生物利用度经计算为102%。讨论涉及肾功能改变对分布参数可能产生的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验